| 4826 | It has been a while but I am back. | kaiser | 09/28/2025 5:45:13 PM |
| 3254 | IDVC 002 X 0021 | kaiser | 02/10/2014 9:53:53 AM |
| 3253 | SREH 002 | kaiser | 02/10/2014 9:40:35 AM |
| 3252 | CPXP 0023 X 0028 | kaiser | 02/10/2014 9:38:09 AM |
| 3251 | IDVC 0021 looks like buyers are moving back in. | kaiser | 02/09/2014 10:55:50 PM |
| 3250 | CPXP 0023 nice move up on Friday. Should move | kaiser | 02/09/2014 10:53:32 PM |
| 3249 | SREH 0017 company should have an update about the | kaiser | 02/09/2014 10:52:10 PM |
| 3248 | IRCE 0008 company should have some very nice | kaiser | 02/09/2014 10:48:18 PM |
| 3247 | LBTG 0004 nice buying on Friday. Chart setting up | kaiser | 02/09/2014 10:46:11 PM |
| 3246 | CPXP 0025 | kaiser | 02/07/2014 3:54:04 PM |
| 3245 | LBTG 0005 | kaiser | 02/07/2014 3:23:55 PM |
| 3244 | LBTG 0004 hitting | kaiser | 02/07/2014 3:19:26 PM |
| 3243 | LBTG 0003 X 0004 | kaiser | 02/07/2014 3:09:41 PM |
| 3242 | CPXP 0019 hitting | kaiser | 02/07/2014 3:07:35 PM |
| 3241 | LBTG 0003 nice hits coming in. Looks ready | kaiser | 02/07/2014 2:52:09 PM |
| 3240 | CPXP 0017 X 0019 | kaiser | 02/07/2014 2:50:07 PM |
| 3239 | SREH 002 company should have big news | kaiser | 02/07/2014 2:30:13 PM |
| 3238 | CPXP 0018 | kaiser | 02/07/2014 2:25:59 PM |
| 3237 | CPXP 0017 | kaiser | 02/07/2014 2:14:43 PM |
| 3236 | CPXP 0015 X 0018 | kaiser | 02/07/2014 2:10:33 PM |
| 3235 | CPXP 0015 hitting | kaiser | 02/07/2014 1:59:25 PM |
| 3234 | IDVC 0017 X 0022 | kaiser | 02/07/2014 1:47:12 PM |
| 3233 | CPXP 0013 X 0015 nice bid in. Looks ready | kaiser | 02/07/2014 1:34:30 PM |
| 3232 | IDVC 0016's going | kaiser | 02/07/2014 1:01:48 PM |
| 3231 | SREH 002 hitting | kaiser | 02/07/2014 12:26:48 PM |
| 3230 | SREH 0019 hearing company should have an update | kaiser | 02/07/2014 12:15:29 PM |
| 3229 | IDVC 0016 hitting | kaiser | 02/07/2014 10:23:03 AM |
| 3228 | IDVC 0016 looks like buyers are moving back in. A | kaiser | 02/06/2014 10:50:11 PM |
| 3227 | IRCE 0008 company should have some very good | kaiser | 02/06/2014 10:43:29 PM |
| 3226 | VMGI 001 | kaiser | 02/06/2014 3:42:05 PM |
| 3225 | IDVC 0016 | kaiser | 02/06/2014 3:24:52 PM |
| 3224 | IDVC 0014 X 0016 nice buying | kaiser | 02/06/2014 2:19:09 PM |
| 3223 | VMGI 0009's going | kaiser | 02/06/2014 2:03:12 PM |
| 3222 | CPXP 0015 | kaiser | 02/06/2014 12:33:48 PM |
| 3221 | CPXP 0013 X 0015 | kaiser | 02/06/2014 12:23:41 PM |
| 3220 | CPXP 0014 nice buying today looks | kaiser | 02/06/2014 12:18:22 PM |
| 3219 | NVNT 005 X 006 | kaiser | 02/06/2014 12:16:52 PM |
| 3218 | VMGI 0008 X 0009 | kaiser | 02/06/2014 11:40:55 AM |
| 3217 | VMGI 0008 | kaiser | 02/06/2014 11:37:14 AM |
| 3215 | VMGI 0007 getting volume looks ready | kaiser | 02/06/2014 11:31:03 AM |
| 3214 | IRCE 0008 X 0009 | kaiser | 02/06/2014 10:52:58 AM |
| 3213 | IRCE 0008 bidders moving in | kaiser | 02/06/2014 10:45:00 AM |
| 3212 | MDIN 0016 | kaiser | 02/06/2014 10:36:21 AM |
| 3211 | NVNT 005 | kaiser | 02/06/2014 10:34:48 AM |
| 3210 | MDIN 0014 | kaiser | 02/06/2014 10:31:53 AM |
| 3209 | CSLI 0005 | kaiser | 02/06/2014 10:24:23 AM |
| 3208 | MDIN 0011 X 0012 | kaiser | 02/06/2014 10:22:22 AM |
| 3207 | NVNT 0045 | kaiser | 02/06/2014 10:20:36 AM |
| 3206 | MDIN 001 | kaiser | 02/06/2014 10:14:04 AM |
| 3205 | MDIN 0009 | kaiser | 02/06/2014 10:12:12 AM |
| 3204 | MDIN 0008 hitting | kaiser | 02/06/2014 10:06:13 AM |
Recent Articles
- Investigation into Avidity Biosciences' Sale to Novartis
- POET Technologies Secures $150 Million in Investment for Growth
- Perseus Mining Reports Strong Operational Results for Q3 2025
- Secure Your Rights: Quantum Corporation Investors Must Act Now
- Investors Urged to Act Ahead of Semler Scientific Class Action
- Cygnus Metals Welcomes New CEO to Spearhead Future Growth
- Cygnus Announces Leadership Changes with New CEO Appointment
- Nyrstar NV Faces Appeal Following FSMA Sanctions Committee Ruling
- MapLight Therapeutics: Pioneering Solutions for CNS Disorders
- MapLight Therapeutics Sets Price for Its Highly Anticipated IPO
- Stay Informed: Key Legal Updates for Dow Inc. Investors
- Medtronic's Innovative Blood Pressure Treatments Show Long-Term Success
- Tronox Holdings PLC Investors Urged to Act Before Deadline
- CAPHRA's Asia Day: A Vital Approach to Tobacco Harm Reduction
- Influential Tech Leaders Shape Policy Decisions on Troops
- Transformative Financial Insights from Warren Buffett for the Elite
- Corporate Giants Fuel Trump's $300 Million Ballroom Dream
- Apple Inc. Enhances iPad Pro with Vapor Chamber Technology
- LifeMD, Inc.: Investors Encouraged to Claim Their Rights
- Breaking News: Louvre Heist Culprits Arrested in France
- Anthony Scaramucci Voices Support for Changpeng Zhao's Pardon
- General Motors Ditches CarPlay: A Shift Towards Innovation
- Exploring Trump's Bold Strategy of Gold for Bitcoin Exchange
- Cristcot Showcases Promising UC Treatment Data at Annual Meeting
- Innovative TissueCypher Test Enhances Management of Barrett's Esophagus
- Seniors Express Concerns as Social Security Payments Increase
- Castle Biosciences Unveils Key Data on TissueCypher at ACG
- Cordis Announces Innovative Results from Groundbreaking Trials
- Shaquille O'Neal's Luxury SUV Stolen in Cyber Heist
- Marex Group plc Securities Class Action Update and Guidance
- How the Fed's Balance Shift Could Impact Bitcoin Prices
- ARETI International Group Sponsors Mayflower Gran Prix 2025
- Big Week for Stocks: Major Gainers and Surprising Trends
- Microsoft's Strategic Shift in AI Development and Ethics
- U.S.-China Trade Agreement: Impact on Economy and Relations
- Recent Trends in Large Cap Stocks: Key Market Movers
- Avidity Biosciences Announces Acquisition by Novartis AG Deal
- Legal Action Encouraged for Designer Brands Inc. Investors
- Exploring the Future of Kratom: Insights from Kratom Bird
- Novartis Enhances Neuroscience Pipeline Through Avidity Biosciences Acquisition
- EggNest™ System: A Breakthrough in Radiation Safety for Cath Labs
- Critical Importance of Court Reporting in High-Profile Trials
- Mark Cuban's Insight: Billionaires and Market Stability
- Blockchain Jungle 2025: Experience Innovation in Technology
- Fortinet Shareholders Urged to Join Securities Class Action
- Controversial $130 Million Donation to Pentagon Raises Concerns
- Fate Therapeutics: Advances in CAR T-Cell Therapy for Lupus
- JPMorgan Faces Legal Challenge Over Excessive Fraud Fees
- JPMorgan Fights $115 Million Legal Fees After Fraud Case
- Fate Therapeutics Unveils Promising Data on FT819 CAR T-Cell Therapy
